スイスのレリーフ・セラピューティクスのサイトカイン症候群治療薬「アヴィプタディル」アメリカの病院で治験中。

NatsukiRisa のブックマーク 2020/05/14 02:10

<blockquote class="hatena-bookmark-comment"><a class="comment-info" href="https://b.hatena.ne.jp/entry/4685657924409560738/comment/NatsukiRisa" data-user-id="NatsukiRisa" data-entry-url="https://b.hatena.ne.jp/entry/s/relieftherapeutics.com/relief-therapeutics-rlfsix-drug-aviptadil-enters-fda-trial-at-thomas-jefferson-university-hospital-in-philadelphia-to-treat-covid-19-induced-acute-respiratory-distress/" data-original-href="https://relieftherapeutics.com/relief-therapeutics-rlfsix-drug-aviptadil-enters-fda-trial-at-thomas-jefferson-university-hospital-in-philadelphia-to-treat-covid-19-induced-acute-respiratory-distress/" data-entry-favicon="https://cdn-ak2.favicon.st-hatena.com/64?url=https%3A%2F%2Frelieftherapeutics.com%2Frelief-therapeutics-rlfsix-drug-aviptadil-enters-fda-trial-at-thomas-jefferson-university-hospital-in-philadelphia-to-treat-covid-19-induced-acute-respiratory-distress%2F" data-user-icon="/users/NatsukiRisa/profile.png">https://relieftherapeutics.com/relief-therapeutics-rlfsix-drug-aviptadil-enters-fda-trial-at-thomas-jefferson-university-hospital-in-philadelphia-to-treat-covid-19-induced-acute-respiratory-distress/</a><ul class="comment-tag" style="list-style: none; margin: 0px;"><li style="float: left">[<a href="https://b.hatena.ne.jp/q/Switzerland">Switzerland</a>]</li><li style="float: left">[<a href="https://b.hatena.ne.jp/q/COVID-19">COVID-19</a>]</li><li style="float: left">[<a href="https://b.hatena.ne.jp/q/Regulation">Regulation</a>]</li></ul><br><p style="clear: left">スイスのレリーフ・セラピューティクスのサイトカイン症候群治療薬「アヴィプタディル」アメリカの病院で治験中。</p><a class="datetime" href="https://b.hatena.ne.jp/NatsukiRisa/20200514#bookmark-4685657924409560738"><span class="datetime-body">2020/05/14 02:10</span></a></blockquote><script src="https://b.st-hatena.com/js/comment-widget.js" charset="utf-8" async></script>

このブックマークにはスターがありません。
最初のスターをつけてみよう！